Skip to main content

Table 2 Summary of 19 cases in which chemotherapy was used for treatment

From: Unresectable primary hepatic adenosquamous carcinoma successfully treated with systemic and transcatheter hepatic arterial injection chemotherapies followed by conversion surgery: a case report and literature review

No.

Regimen

Object

Administration route

Response

Prognosis

References

1

5-FU + CDDP

Adj

Intravenously

NR

Alive, 8 months after surgery

[27]

2

GEM + S-1

Adj

Intravenously

NR

Alive, 8 months after surgery

[37]

3

5-FU

Adj

Intravenously

NR

Alive, 15 months after surgery

[21]

4

Capecitabine

Adj

Oral

NR

Alive, 15 months after surgery

[46]

5

Sorafenib

Adj

Oral

NR

Alive, 7 months after surgery

[46]

6

Capecitabine

Adj

Oral

R

Dead

[46]

7

contents unknown

Adj

n.a

R

Dead, 8 months after surgery

[19]

8

contents unknown

Chemo

n.a

PD

Dead

[20]

9

contents unknown

Chemo

n.a

PD

Dead

[46]

10

contents unknown

Chemo

n.a

PD

Dead

[46]

11

contents unknown

Chemo

n.a

PD

Dead

[46]

12

5-FU + CDDP

Chemo

TAI

PD

Dead, 14 months after diagnosis

[45]

13

5-FU + CDDP

Chemo

TAI

PD

Dead, 13 months after diagnosis

[36]

14

GEM + CDDP

Chemo

Intravenously

PD

Dead

[39]

15

GEM + S-1

Chemo

Intravenously

PD

Dead, 10 months after surgery

[17]

16

5-FU + CDDP

Chemo

TAI

PR

Alive, 8 months after chemo

[28]

17

5-FU + CDDP

Chemo

TAI

PR

Alive, 8 months after chemo

[29]

18

GEM + CDDP

Chemo

Intravenously

PR

Alive, 11 months after surgery

[41]

19

S-1 + CDDP

Conversion therapy

TAI

PR

Alive, 6 months after surgery

Our case

  1. Adj, Adjuvant chemotherapy; Cx, Chemotherapy; CDDP, cisplatin; GEM, gemcitabine; n.a., not applicable; No., number; NR, no recurrence; PD, progressive disease; PR, partial remission; R, recurrence; Ref, Reference; S-1, Tegafur/Gimeracil/Oteracil; TAI, transcatheter hepatic arterial injection; 5-FU, 5-fluorouracil